FDA official: Patients play an increasing role in rare disease drug development
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsNorth AmericaPharmaceuticalsProduct LifecycleResearch, Design and Development